Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. - Kuerer,H.M.; Newman,L.A.; Smith,T.L.; Ames,F.C.; Hunt,K.K.; Dhingra,K.; Theriault,R.L.; Singh,G.; Binkley,S.M.; Sneige,N.; Buchholz,T.A.; Ross,M.I.; et al. (J Clin Oncol, 1999)